Clinicopathological relevance of antithyroglobulin antibodies in low-risk papillary thyroid cancer.Published in:Clinical Otolaryngology, 2017, v. 42, n. 6, p. 1130, doi. 10.1111/coa.12835By:Morand, G.B.;Silva, S.D.;Mlynarek, A.M.;Black, M.J.;Payne, R.J.;Hier, M.P.Publication type:Article